ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHAHID RIAZ MD

Neurology

2,806

$258K

421
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 27%

$92
Average prescription price

Avg: $204

MELVIN GROSSMAN MD

Neurology

2,799

$347K

240
126 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $204

LOIUS BUTERA DO

Neurology

2,796

$486K

356
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$174
Average prescription price

Avg: $204

JAMES STAFFORD DO

Neurology

2,796

$554K

403
368 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $204

DONALD NEGROSKI MD

Neurology

2,782

$2.22M

379
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 27%

$797
Average prescription price

Avg: $204

ARDESHIR KHADEMI-KERMANSHAHI MD

Neurology

2,750

$712K

382
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$259
Average prescription price

Avg: $204

KESTER NEDD DO

Neurology

2,740

$230K

185
81 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $204

GERY FLOREK MD

Neurology

2,736

$510K

240
173 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$187
Average prescription price

Avg: $204

MATTHEW BAKER MD

Neurology

2,718

$946K

358
270 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$348
Average prescription price

Avg: $204

MANDEEP GAREWAL MD

Neurology

2,684

$575K

390
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$214
Average prescription price

Avg: $204

DANIEL TRAVIESA MD

Neurology

2,676

$743K

382
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$278
Average prescription price

Avg: $204

TRACEY CERBONE M.D.

Neurology

2,668

$479K

311
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$179
Average prescription price

Avg: $204

JULIO CANTERO MD

Neurology

2,668

$394K

256
185 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$147
Average prescription price

Avg: $204

DAVID BEAR D.O.

Neurology

2,667

$570K

301
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$214
Average prescription price

Avg: $204

ERIN DOTY MD

Neurology

2,667

$539K

384
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$202
Average prescription price

Avg: $204

MARK RUBINO MD

Neurology

2,633

$495K

171
105 are 65+

32%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$188
Average prescription price

Avg: $204

STEPHEN ROSENBERG MD

Neurology

2,626

$1.91M

263
66 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$728
Average prescription price

Avg: $204

SHERRILL LORING MD

Neurology

2,612

$3.74M

197
24 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 27%

$1431
Average prescription price

Avg: $204

ANABELLE MALDONADO-MEDINA MD

Neurology

2,571

$293K

229
162 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$114
Average prescription price

Avg: $204

PRAVINCHANDRA ZALA MD

Neurology

2,565

$850K

428
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$332
Average prescription price

Avg: $204

CARRIE LANDESS M.D., P.A

Neurology

2,563

$270K

443
304 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $204

JOSE POZO MD

Neurology

2,563

$193K

346
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $204

DANIEL CABELLO M.D.

Neurology

2,557

$547K

231
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$214
Average prescription price

Avg: $204

THOMAS HAMMOND MD

Neurology

2,544

$287K

269
232 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $204

DAVID SILVERS M.D

Neurology

2,543

$504K

256
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank